BAX
Baxter InternationalStock · HealthcareS&P 500 Equal Weight 0.2% · S&P 500 0.02% · Russell 1000 0.02% · US Stock Market 0.02% · Russell 3000 0.01%$22.80-0.96%
as of market close, Sep 18, 2026
☾ AH $22.80 +0.00%
BAX — Baxter International price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD
20.030.040.050.060.070.080.090.0050.0M100.0M$22.80—20162019202120242026
2026-09-18
Price$22.80
MA20$21.64
MA50$21.29
Vol32.2M
Key stats
Price data
- Price
- $22.80
- Change YTD
- +19.31%
- Next earnings
- Oct 29, 2026
- Market cap
- 11.8B
- Enterprise value
- 19.4B
- Shares outstanding
- 517M
- 52W low
- $15.73
- 52W high
- $30.00
- From 52W high
- -24.00%
- From 52W low
- +44.95%
- 52W range
- 50%
- Beta
- 0.59
Volume
- Rel volume
- 1.74×
- 30D volume
- 5.7M
- 30D $ vol
- 146.3M
Fundamentals
- Sales (ttm)
- 11.5B
- Sales/share
- $22.19
- EPS (ttm)
- -$2.07
- FCF (ttm)
- 332M
- FCF/share
- $0.64
- Book value/share
- $12.00
- Net margin
- -9.27%
- ROE
- -17.13%
- ROA
- -5.37%
- Debt / equity
- 1.52×
- Current ratio
- 1.95
Growth (CAGR, ttm) · 10Y
- Sales
- +5.36%-2.53%-1.22%+1.33%
- FCF
- -42.08%-26.43%-22.13%-9.08%
- Shares
- +0.66%+0.69%+0.67%-0.51%
Per-share growth (CAGR, ttm) · 10Y
- Sales/share
- +4.67%-3.20%-1.88%+1.85%
- FCF/share
- -42.40%-26.90%-22.41%-8.50%
- Book value/share
- -15.78%+2.96%-6.71%-2.61%
- Dividend/share
- -75.02%-44.34%-27.74%-8.29%
- Price
- -3.76%-16.19%-22.88%-7.03%
- Total return
- -3.57%-14.61%-21.35%-5.59%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- -11.0×
- P/OI (ttm)
- 1233.4×
- Fwd P/E
- 11.6×
- P/S (ttm)
- 1.0×
- P/B (mrq)
- 1.9×
- P/FCF (ttm)
- 35.5×
- EV/EBITDA (fy)
- 28.5×
- EV/Sales (ttm)
- 1.7×
- FCF yield (ttm)
- 2.82%
- Dividend yield (fwd)
- 0.88%
- Dividend/share (fwd)
- $0.20
- Buyback yield (realized, 1y)
- -0.66%
- Shareholder yield (realized, 1y)
- 0.53%
- Buyback yield (cash, ttm)
- 0.00%
- Shareholder yield (cash, ttm)
- 1.56%
Vs own 10Y history
- P/E
- 97th
- P/OI
- 99th
- P/S
- 7th
- P/B
- 10th
- P/FCF
- 92nd
Bar = where today’s multiple sits in BAX’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-09-18
1D
-0.96%
5D
-4.20%
1M
-12.10%
3M
+14.63%
YTD
+19.31%
1Y
-3.76%
5Y
-72.73%
Financial statements
Open full BAX financials →Loading financial statements…
Related Healthcare
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | -5.94% | +0.04% |
| JNJ | Johnson & Johnson | -0.41% | -0.09% |
| ABBV | AbbVie Inc. | +1.95% | -0.02% |
| MRK | Merck & Co. Inc. | +8.66% | -0.19% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | -4.32% | +0.45% |
| TMO | Thermo Fisher Scientific Inc. | +10.60% | -1.04% |
| AMGN | Amgen Inc. | -9.32% | +1.55% |
| GILD | Gilead Sciences Inc. | +4.65% | -0.52% |
Baxter International (BAX) trades at $22.80 with a live price and an interactive chart covering 44+ years of daily price history, plus key valuation metrics. ChartRow also publishes BAX’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full BAX financial statements →
